Subscribe
shutterstock_384310168_doro_guzenda
Doro Guzenda / Shutterstock.com
19 April 2022MedtechFran Salisbury and Alice Jefferies

Predicting the unpredictable during pregnancy

A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More features

CREATES Act unfairly tips the scales to generics
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages
Comparing life sciences IP in Brazil and the US
White & Case hires experienced litigator from A&O Shearman
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst